Assessment of the Anti-Amyloidogenic Properties of Essential Oils and Their Constituents in Cells Using a Whole-Cell Recombinant Biosensor
Essential oils exhibit numerous medicinal properties, including antimicrobial, anti-inflammatory and antioxidant effects. Recent studies also indicate that certain essential oils demonstrate anti-amyloidogenic activity against β-amyloid, the protein implicated in Alzheimer's disease. To investigate whether the anti-aggregating properties of essential oils extend to α-synuclein, the protein involved in Parkinson's disease, we constructed and employed a whole-cell biosensor based on the split-luciferase complementation assay. We validated our biosensor by using baicalein, a known inhibitor of α-synuclein aggregation, and subsequently we tested eight essential oils commonly used in food and the hygienic industry. Two of them, citron and sage, along with their primary components, pure linalool (the main constituent in citron essential oil) and pure eucalyptol (1,8-cineole, the main constituent in sage essential oil), were able to reduce α-syn aggregation. These findings suggest that both essential oils and their main constituents could be regarded as potential components in functional foods or incorporated into complementary Parkinson's disease therapies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Brain sciences - 14(2023), 1 vom: 29. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stylianopoulou, Electra [VerfasserIn] |
---|
Links: |
---|
Themen: |
α-synuclein |
---|
Anmerkungen: |
Date Revised 28.01.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/brainsci14010035 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367387433 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367387433 | ||
003 | DE-627 | ||
005 | 20240128231948.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240122s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/brainsci14010035 |2 doi | |
028 | 5 | 2 | |a pubmed24n1273.xml |
035 | |a (DE-627)NLM367387433 | ||
035 | |a (NLM)38248250 | ||
035 | |a (PII)35 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stylianopoulou, Electra |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of the Anti-Amyloidogenic Properties of Essential Oils and Their Constituents in Cells Using a Whole-Cell Recombinant Biosensor |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.01.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Essential oils exhibit numerous medicinal properties, including antimicrobial, anti-inflammatory and antioxidant effects. Recent studies also indicate that certain essential oils demonstrate anti-amyloidogenic activity against β-amyloid, the protein implicated in Alzheimer's disease. To investigate whether the anti-aggregating properties of essential oils extend to α-synuclein, the protein involved in Parkinson's disease, we constructed and employed a whole-cell biosensor based on the split-luciferase complementation assay. We validated our biosensor by using baicalein, a known inhibitor of α-synuclein aggregation, and subsequently we tested eight essential oils commonly used in food and the hygienic industry. Two of them, citron and sage, along with their primary components, pure linalool (the main constituent in citron essential oil) and pure eucalyptol (1,8-cineole, the main constituent in sage essential oil), were able to reduce α-syn aggregation. These findings suggest that both essential oils and their main constituents could be regarded as potential components in functional foods or incorporated into complementary Parkinson's disease therapies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Gaussia princeps | |
650 | 4 | |a Parkinson’s disease | |
650 | 4 | |a citron | |
650 | 4 | |a essential oils | |
650 | 4 | |a eucalyptol | |
650 | 4 | |a linalool | |
650 | 4 | |a sage | |
650 | 4 | |a split-luciferase assay | |
650 | 4 | |a α-synuclein | |
700 | 1 | |a Daviti, Anastasia |e verfasserin |4 aut | |
700 | 1 | |a Giourou, Venetia |e verfasserin |4 aut | |
700 | 1 | |a Gerasimidi, Eleni |e verfasserin |4 aut | |
700 | 1 | |a Nikolaou, Anastasios |e verfasserin |4 aut | |
700 | 1 | |a Kourkoutas, Yiannis |e verfasserin |4 aut | |
700 | 1 | |a Grigoriou, Maria E |e verfasserin |4 aut | |
700 | 1 | |a Paleologou, Katerina E |e verfasserin |4 aut | |
700 | 1 | |a Skavdis, George |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Brain sciences |d 2011 |g 14(2023), 1 vom: 29. Dez. |w (DE-627)NLM227436393 |x 2076-3425 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2023 |g number:1 |g day:29 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/brainsci14010035 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2023 |e 1 |b 29 |c 12 |